EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Unraveling the Whipple Triad: Non–Islet Cell Tumor–Induced Hypoglycemia

Farzahna Mohamed iD, Frederick J Raal iD

JCEM Case Reports · 08.01.2024 · 2 (2)

DOI: 10.1210/jcemcr/luae006 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 27.01.2024. Verfasst von Farzahna Mohamed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, 2193, South Africa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-induced hypoglycemia (TIH) is a rare paraneoplastic phenomenon resulting from several tumor types and mechanisms. Insulinomas are the most common cause of TIH. However, non–islet cell tumors can also trigger hypoglycemia by releasing insulin-like growth factor 2 (IGF-II) or its precursor. We present a case of a 56-year-old woman experiencing spontaneous hypoglycemia due to a pleural-based solitary fibrous tumor. Diagnostic evaluations revealed diminished C-peptide levels, increased IGF-II, and a 4-fold increase in the IGF-II: IGF-I ratio, indicative of non–islet cell tumor hypoglycemia. Localization imaging identified a left pleural mass, confirming the diagnosis. Preoperatively, the patient received intravenous dextrose and corticosteroids, but surgical resection was essential for the resolution of symptoms. The identified tumor, a benign solitary fibrous tumor, was successfully removed, leading to an immediate postoperative cessation of hypoglycemia. Six years post resection, the patient remains symptom free. Managing TIH necessitates an early diagnosis aiming for complete tumor resection, with alternative approaches considered when complete resection is not possible. This case highlights the importance of a systematic diagnostic and management approach for TIH, emphasizing the need to identify the underlying cause, particularly in people without diabetes.

Schlagwörter

Stichwörter der Autor:innen

hypoglycemiainsulin-like growth factornon–islet cell tumor

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, 2193, South Africa.

ORCID-Profile: Farzahna Mohamed, Frederick J Raal

Zitieren

APA

Mohamed, F., & Raal, F. J. (2024). Unraveling the Whipple Triad: Non–Islet Cell Tumor–Induced Hypoglycemia. JCEM Case Reports, 2(2). https://doi.org/10.1210/jcemcr/luae006

Vancouver

Mohamed F, Raal FJ. Unraveling the Whipple Triad: Non–Islet Cell Tumor–Induced Hypoglycemia. JCEM Case Reports. 2024;2(2). doi:10.1210/jcemcr/luae006

BibTeX
@article{Mohamed2024,
  author = {Mohamed, Farzahna and Raal, Frederick J},
  title = {Unraveling the Whipple Triad: Non–Islet Cell Tumor–Induced Hypoglycemia},
  journal = {JCEM Case Reports},
  year = {2024},
  volume = {2},
  number = {2},
  doi = {10.1210/jcemcr/luae006}
}
Kostenlos starten →